drugset / Trial / NCT03065192
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
Safety and efficacy of AADC gene transfer in participants with Parkinson's disease.
Timeline
- Start
- 2017-05-11
- Primary completion
- 2021-08-10
- Completion
- 2021-08-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VY-AADC01 | Gene therapy (AAV / viral vector) | 9.4e+12 vg | Other |